ORIENT BIO INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 543 KRW | +1.31% |
|
-4.57% | -10.54% |
| Sales 2020 | 37.7B 27.37M | Sales 2021 | 52.02B 37.77M | Capitalization | 187B 136M |
|---|---|---|---|---|---|
| Net income 2020 | -10.88B -7.9M | Net income 2021 | -15.63B -11.35M | EV / Sales 2020 | 1.66 x |
| Net Debt 2020 | 4.07B 2.95M | Net cash position 2021 | 3.63B 2.64M | EV / Sales 2021 | 3.53 x |
| P/E ratio 2020 |
-5.36
x | P/E ratio 2021 |
-11.4
x | Employees | 125 |
| Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 64.38% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.31% | ||
| 1 week | -4.57% | ||
| Current month | -9.20% | ||
| 1 month | -3.89% | ||
| 3 months | -9.50% | ||
| 6 months | -9.95% | ||
| Current year | -10.54% |
1 week
523.00
563.00
1 month
523.00609.00
Current year
523.00632.00
1 year
523.00897.00
3 years
523.001 900.00
5 years
401.002 620.00
10 years
401.007 296.80
| Managers | Title | Age | Since |
|---|---|---|---|
Jae-Jin Jang
CEO | Chief Executive Officer | 63 | - |
Tae-Seok Han
PRN | Corporate Officer/Principal | 47 | - |
Sang-Nyeon Kim
PRN | Corporate Officer/Principal | 64 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jae-Jin Jang
CEO | Chief Executive Officer | 63 | - |
Sook-Jong Choi
BRD | Director/Board Member | 59 | - |
Kang-Moon Choi
BRD | Director/Board Member | 56 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 543 | +1.31% | 123,857 |
| 24-04-17 | 536 | 0.00% | 89,701 |
| 24-04-16 | 536 | -1.83% | 149,233 |
| 24-04-15 | 546 | -3.19% | 220,392 |
| 24-04-12 | 564 | -0.88% | 107,933 |
End-of-day quote Korea S.E., April 17, 2024
More quotes
ORIENT BIO Inc. is a Korea-based company engaged in the biotechnology area. The Company produces and supplies laboratory animals, including mice, rats, guinea pigs, hamsters, specific pathogen free (SPF) rabbits, beagles and others. It also provides contract research organization (CRO) services, including CRO safety assessment and CRO new drug development services; medical and library equipment, such as barrier systems, and support services such as rodent surgery services, laboratory diagnostics services, transgenic services, genetic testing services and other services. In addition, along with its subsidiaries, the Company provides feeds, reagents, disinfectants, automobile components, power supply equipment, and other machines.
Calendar
2024-08-13
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -10.54% | 46.77M | |
| -2.71% | 102B | |
| +2.66% | 96.07B | |
| -1.25% | 21.66B | |
| -18.14% | 20.77B | |
| -7.40% | 18.53B | |
| -40.31% | 16.91B | |
| -28.46% | 13.79B | |
| +0.77% | 13.33B | |
| +21.32% | 10.94B |
- Stock Market
- Equities
- A002630 Stock
